Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)

Market Cap	25.89B +47.7%
Revenue (ttm)	4.67B +6.8%
Net Income	1.25B +4.8%
EPS	1.36 +4.6%
Shares Out	921.32M
PE Ratio	20.65
Forward PE	19.51
Dividend	0.60 (2.04%)
Ex-Dividend Date	Jun 6, 2025

Volume	9,458,423
Average Volume	12,303,335
Open	29.00
Previous Close	29.35
Day's Range	28.00 - 29.39
52-Week Range	19.01 - 47.37
Beta	0.14
RSI	32.14
Earnings Date	Apr 23, 2026

About SHE:002773

Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and distribution of medicine for ophthalmic, neuropsychiatric and other applications in China. It also develops a pipeline of clinical and pre-clinical programs for ophthalmology, CNS, oncology, and common disease. The company was founded in 1996 and is based in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 4,462
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002773

Financial Performance

In 2024, SHE:002773's revenue was 4.45 billion, an increase of 12.51% compared to the previous year's 3.96 billion. Earnings were 1.19 billion, an increase of 14.02%.